ESCRS - Joint venture ;

ESCRS - Joint venture ;

Joint venture

Heidelberg Engineering and Gauss Medical Corporation, have established a joint venture for the supply of healthcare IT solutions to the Chinese ophthalmology market

Joint venture

Colin Kerr

Published: Thursday, March 2, 2017

Heidelberg Engineering and its long-time distribution partner in China, Gauss Medical Corporation, have established a joint venture for the supply of healthcare IT solutions to the Chinese ophthalmology market. The joint venture company will offer picture archiving and communication systems (PACS) and electronic medical record (EMR) software. “The establishment of this joint venture with Heidelberg Engineering comes at a time of growing demand for advanced ophthalmic IT solutions in China,” said Mr Liu Xidong, chairman and CEO of Gauss Infomed.  www.heidelberg engineering.com

Latest Articles

Glaucoma Treatment Under Pressure

New techniques and technologies add to surgeons’ difficult decisions

Outside the Box, Inside the Pipeline

Researchers are tackling glaucoma diagnosis and treatment from all sides.

The EHDS Is Ready for the Green Light

If proposal is approved, Europe could see better access to, and exchange and use of, health data.

ESCRS to Release Guidelines for Cataract and Refractive Surgery

Comprehensive approach to the safest and most effective modern surgery.

Barry Fellowship Opens Up ‘Whole New Field of Thought’

The 2022 recipient combines theoretical and practical to learn new treatments.

Digitalising the OR—Experience and Perspectives

Benefits include saving time and improving outcomes.

ESCRS Heritage Programme

Visionaries past and present.

Dynamic Measures Needed for Quality of Vision

Functional visual acuity testing and straylight metering may better reflect real-world conditions.

What Is Stopping Digital OR Adoption?

Ophthalmologists know the benefits—now it’s time to construct the right plan.

Time to Move Beyond Monofocal IOLs?

European surgeons appear hesitant to first offer other presbyopia-correcting options to patients.

;